SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Sunovion Pharmaceuticals Inc. Release: Latuda(R) (lurasidone HCl) was Associated with Low Rates of Weight Gain and Metabolic Changes in Patients with Schizophrenia in Data Presented at the 164th Meeting of the American Psychiatric Association